Literature DB >> 8498395

Sleep apnea in male patients with the fibromyalgia syndrome.

Kimberly P May1, Sterling G West1, Michael R Baker1, David W Everett2.   

Abstract

PURPOSE: Fibromyalgia is a common pain syndrome that is often associated with sleep disturbances. The most characteristic pattern noted on formal sleep study is alpha-wave intrusion on delta-wave sleep. This nonrestorative sleep pattern may be endogenous, or caused by any of a number of sleep disturbances. Our goal was to determine the frequency of sleep apnea and its relationship to a nonrestorative sleep pattern in our patients with fibromyalgia syndrome. PATIENTS AND METHODS: All new fibromyalgia patients seen in the Rheumatology Clinic at Fitzsimons Army Medical Center were screened using history and physical examination for suspicion of sleep apnea. When this condition was suspected, the patients underwent formal polysomnography to delineate any sleep disturbance.
RESULTS: Four of 92 women, and 13 of 25 men with the new diagnosis of fibromyalgia syndrome underwent polysomnography. Of the women, 2.2% (2 of 92) had significant sleep apnea at formal evaluation; both were obese and had obstructive findings. In contrast, 44% (11 of 25) of the men had significant sleep apnea.
CONCLUSIONS: Sleep apnea is not a significant cause of fibromyalgia symptoms in females. In male patients with fibromyalgia, sleep apnea was observed in a large percentage. Fibromyalgia may be a marker for occult sleep apnea in males.

Entities:  

Mesh:

Year:  1993        PMID: 8498395     DOI: 10.1016/0002-9343(93)90085-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

1.  Treatment of fibromyalgia with antidepressants: a meta-analysis.

Authors:  P G O'Malley; E Balden; G Tomkins; J Santoro; K Kroenke; J L Jackson
Journal:  J Gen Intern Med       Date:  2000-09       Impact factor: 5.128

2.  Evaluating Evidence for the Role of Sleep in Fibromyalgia: A Test of the Sleep and Pain Diathesis Model.

Authors:  Nancy A Hamilton; Mindy Pressman; Teresa Lillis; Ruthann Atchley; Cynthia Karlson; Natalie Stevens
Journal:  Cognit Ther Res       Date:  2012-12-01

Review 3.  Fibromyalgia and sleep in animal models: a current overview and future directions.

Authors:  Cristina Frange; Camila Hirotsu; Helena Hachul; Paula Araujo; Sergio Tufik; Monica L Andersen
Journal:  Curr Pain Headache Rep       Date:  2014

Review 4.  Sleep disorders and fibromyalgia.

Authors:  Suely Roizenblatt; Nilton Salles Rosa Neto; Sergio Tufik
Journal:  Curr Pain Headache Rep       Date:  2011-10

5.  Modafinil Increases Awake EEG Activation and Improves Performance in Obstructive Sleep Apnea during Continuous Positive Airway Pressure Withdrawal.

Authors:  David Wang; Xiao Xue Bai; Shaun C Williams; Shu Cheng Hua; Jong-Won Kim; Nathaniel S Marshall; Angela D'Rozario; Ronald R Grunstein
Journal:  Sleep       Date:  2015-08-01       Impact factor: 5.849

6.  Objective measures of disordered sleep in fibromyalgia.

Authors:  Ronald D Chervin; Mihaela Teodorescu; Ramesh Kushwaha; Andrea M Deline; Christine B Brucksch; Christine Ribbens-Grimm; Deborah L Ruzicka; Phyllis K Stein; Daniel J Clauw; Leslie J Crofford
Journal:  J Rheumatol       Date:  2009-08-14       Impact factor: 4.666

7.  Obstructive sleep apnea syndrome as an uncommon cause of fibromyalgia: a case report.

Authors:  Vesile Sepici; Aliye Tosun; Oğuz Köktürk
Journal:  Rheumatol Int       Date:  2007-06-23       Impact factor: 2.631

Review 8.  Classification, epidemiology, and natural history of fibromyalgia.

Authors:  K P White; M Harth
Journal:  Curr Pain Headache Rep       Date:  2001-08

9.  Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study.

Authors:  Harvey Moldofsky; John Patcai
Journal:  BMC Neurol       Date:  2011-03-24       Impact factor: 2.474

10.  Decrease of Serum IGF-1 Level is Not Associated With Obstructive Sleep Apnea in Fibromyalgia Patients.

Authors:  Emrullah Hayta; Ayşe Altun Okşaşoğlu
Journal:  Arch Rheumatol       Date:  2016-10-19       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.